Skip to main content
Erschienen in: Inflammation 4/2016

02.05.2016 | ORIGINAL ARTICLE

Isorhamnetin ameliorates LPS-induced inflammatory response through downregulation of NF-κB signaling

verfasst von: Yang Li, Gefu Chi, Bingyu Shen, Ye Tian, Haihua Feng

Erschienen in: Inflammation | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Isorhamnetin, a flavonoid mainly found in Hippophae fhamnoides L. fruit, has been known for its antioxidant activity and its ability to regulate immune response. In this study, we investigated whether isorhamnetin exerts potent antiinflammatory effects in RAW264.7 cell and mouse model stimulated by LPS. The cytokine (TNF-α, IL-1β, and IL-6) levels were determined. In the mouse model of acute lung injury, the phosphorylation of NF-κB proteins was analyzed and inhibitor of NF-κB signaling (PDTC) was used on mice. Our results showed that isorhamnetin markedly decreased TNF-α, IL-1β, and IL-6 concentrations and suppressed the activation of NF-κB signaling. Meanwhile, isorhamnetin reduced the amount of inflammatory cells, the lung wet-to-dry weight ratio, protein leakage, and myeloperoxidase activity. Interference with specific inhibitor revealed that isorhamnetin-mediated suppression of cytokines and protein was via NF-κB signaling. So, it suggests that isorhamnetin might be a potential therapeutic agent for preventing inflammatory diseases.
Literatur
1.
Zurück zum Zitat Helmick, C.G., D.T. Felson, R.C. Lawrence, S. Gabriel, R. Hirsch, C.K. Kwoh, M.H. Liang, H.M. Kremers, M.D. Mayes, P.A. Merkel, S.R. Pillemer, J.D. Reveille, and J.H. Stone. 2008. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis and Rheumatism 58: 15–25.CrossRefPubMed Helmick, C.G., D.T. Felson, R.C. Lawrence, S. Gabriel, R. Hirsch, C.K. Kwoh, M.H. Liang, H.M. Kremers, M.D. Mayes, P.A. Merkel, S.R. Pillemer, J.D. Reveille, and J.H. Stone. 2008. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis and Rheumatism 58: 15–25.CrossRefPubMed
2.
Zurück zum Zitat Lawrence, R.C., D.T. Felson, C.G. Helmick, L.M. Arnold, H. Choi, R.A. Deyo, S. Gabriel, R. Hirsch, M.C. Hochberg, G.G. Hunder, J.M. Jordan, J.N. Katz, H.M. Kremers, and F. Wolfe. 2008. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis and Rheumatism 58: 26–35.CrossRefPubMedPubMedCentral Lawrence, R.C., D.T. Felson, C.G. Helmick, L.M. Arnold, H. Choi, R.A. Deyo, S. Gabriel, R. Hirsch, M.C. Hochberg, G.G. Hunder, J.M. Jordan, J.N. Katz, H.M. Kremers, and F. Wolfe. 2008. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis and Rheumatism 58: 26–35.CrossRefPubMedPubMedCentral
3.
4.
Zurück zum Zitat Brigham, K.L., and B. Meyrick. 1986. Endotoxin and lung injury. American Review of Respiratory Disease 133: 913–927.PubMed Brigham, K.L., and B. Meyrick. 1986. Endotoxin and lung injury. American Review of Respiratory Disease 133: 913–927.PubMed
5.
Zurück zum Zitat Kim, T.H., H.J. Yoon, C.M. Lim, E.K. Kim, M.J. Kim, and Y. Koh. 2005. The role of endogenous histamine on the pathogenesis of the lipopoly-saccharide (LPS)-induced acute lung injury: a pilot study. Inflammation 29: 72–80.CrossRefPubMed Kim, T.H., H.J. Yoon, C.M. Lim, E.K. Kim, M.J. Kim, and Y. Koh. 2005. The role of endogenous histamine on the pathogenesis of the lipopoly-saccharide (LPS)-induced acute lung injury: a pilot study. Inflammation 29: 72–80.CrossRefPubMed
6.
Zurück zum Zitat Matthay, M.A., and G.A. Zimmerman. 2005. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. American Journal of Respiratory Cell and Molecular Biology 33: 319–327.CrossRefPubMedPubMedCentral Matthay, M.A., and G.A. Zimmerman. 2005. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. American Journal of Respiratory Cell and Molecular Biology 33: 319–327.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Libby, P. 2000. Coronary artery injury and the biology of atherosclerosis: In ammation, thrombosis, and stabilization. American Journal of Cardiology 86: 3J–8J (discussion 8 J-9 J).CrossRefPubMed Libby, P. 2000. Coronary artery injury and the biology of atherosclerosis: In ammation, thrombosis, and stabilization. American Journal of Cardiology 86: 3J–8J (discussion 8 J-9 J).CrossRefPubMed
8.
Zurück zum Zitat Bone, R.C. 1996. The sepsis syndrome. Definition and general approach to management. Clinics in Chest Medicine 17: 175–181.CrossRefPubMed Bone, R.C. 1996. The sepsis syndrome. Definition and general approach to management. Clinics in Chest Medicine 17: 175–181.CrossRefPubMed
10.
Zurück zum Zitat Venaille, T.J., G. Ryan, and B.W. Robinson. 1998. Epithelial cell damage is induced by neutrophil-derived, not pseudomonas-derived, proteases in cystic fibrosis sputum. Respiratory Medicine 92: 233–240.CrossRefPubMed Venaille, T.J., G. Ryan, and B.W. Robinson. 1998. Epithelial cell damage is induced by neutrophil-derived, not pseudomonas-derived, proteases in cystic fibrosis sputum. Respiratory Medicine 92: 233–240.CrossRefPubMed
11.
Zurück zum Zitat Kim, H.J., H.S. Lee, Y.H. Chong, and J.L. Kang. 2006. p38 mitogen-activated protein kinas up-regulates LPS-induced NF-κB activation in the development of lung injury and RAW 264.7 macrophages. Toxicology 225: 36–47.CrossRefPubMed Kim, H.J., H.S. Lee, Y.H. Chong, and J.L. Kang. 2006. p38 mitogen-activated protein kinas up-regulates LPS-induced NF-κB activation in the development of lung injury and RAW 264.7 macrophages. Toxicology 225: 36–47.CrossRefPubMed
13.
Zurück zum Zitat Ghosh, S., M.J. May, and E.B. Kopp. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annual Review of Immunology 16: 225–260.CrossRefPubMed Ghosh, S., M.J. May, and E.B. Kopp. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annual Review of Immunology 16: 225–260.CrossRefPubMed
14.
Zurück zum Zitat Baeuerle, P.A., and T. Henkel. 1994. Function and activation of NF-kappa B in the immune system. Annual Review of Immunology 12: 141–179.CrossRefPubMed Baeuerle, P.A., and T. Henkel. 1994. Function and activation of NF-kappa B in the immune system. Annual Review of Immunology 12: 141–179.CrossRefPubMed
15.
Zurück zum Zitat Yang, R., L. Yang, X. Shen, W. Cheng, B. Zhao, K.H. Ali, Z. Qian, and H. Ji. 2012. Suppression of NF-κB pathway by crocetin contributes to attenuation of lipopolysaccharide-induced acute lung injury in mice. European Journal of Pharmacology 674: 391–396.CrossRefPubMed Yang, R., L. Yang, X. Shen, W. Cheng, B. Zhao, K.H. Ali, Z. Qian, and H. Ji. 2012. Suppression of NF-κB pathway by crocetin contributes to attenuation of lipopolysaccharide-induced acute lung injury in mice. European Journal of Pharmacology 674: 391–396.CrossRefPubMed
16.
Zurück zum Zitat Lee, H.J., H.J. Lee, E.O. Lee, S.G. Ko, H.S. Bae, C.H. Kim, K.S. Ahh, J. Lu, and S.H. Kim. 2008. Mitochondria-cytochrome C-caspase-9 cascade mediates isorhamnetin-induced apoptosis. Cancer Letters 270: 342–353.CrossRefPubMed Lee, H.J., H.J. Lee, E.O. Lee, S.G. Ko, H.S. Bae, C.H. Kim, K.S. Ahh, J. Lu, and S.H. Kim. 2008. Mitochondria-cytochrome C-caspase-9 cascade mediates isorhamnetin-induced apoptosis. Cancer Letters 270: 342–353.CrossRefPubMed
17.
Zurück zum Zitat Boesch-Saadatmandi, C., S. Egert, C. Schrader, X. Coumoul, R. Barouki, M.J. Muller, S. Wolffram, and G. Rimbach. 2010. Effect of quercetin on paraoxonase 1 activity-studies in cultured cells, mice and humans. Journal of Physiology and Pharmacology 61: 99–105.PubMed Boesch-Saadatmandi, C., S. Egert, C. Schrader, X. Coumoul, R. Barouki, M.J. Muller, S. Wolffram, and G. Rimbach. 2010. Effect of quercetin on paraoxonase 1 activity-studies in cultured cells, mice and humans. Journal of Physiology and Pharmacology 61: 99–105.PubMed
18.
Zurück zum Zitat Jiang, J.S., C.M. Shih, S.H. Wang, T.T. Chen, C.N. Lin, and W.C. Ko. 2006. Mechanisms of suppression of nitric oxide production by 3-O-methylquercetin in RAW 264.7 cells. Journal of Ethnopharmacology 103: 281–287.CrossRefPubMed Jiang, J.S., C.M. Shih, S.H. Wang, T.T. Chen, C.N. Lin, and W.C. Ko. 2006. Mechanisms of suppression of nitric oxide production by 3-O-methylquercetin in RAW 264.7 cells. Journal of Ethnopharmacology 103: 281–287.CrossRefPubMed
19.
Zurück zum Zitat Yang, J.H., S.C. Kim, B.Y. Shin, S.H. Jin, M.J. Jo, K.H. Jegal, Y.W. Kim, J.R. Lee, S.K. Ku, I.J. Cho, and S.H. Ki. 2013. O-methylated flavonol isorhamnetin prevents acute inflammation through blocking of NF-κB activation. Food and Chemical Toxicology 59: 362–372.CrossRefPubMed Yang, J.H., S.C. Kim, B.Y. Shin, S.H. Jin, M.J. Jo, K.H. Jegal, Y.W. Kim, J.R. Lee, S.K. Ku, I.J. Cho, and S.H. Ki. 2013. O-methylated flavonol isorhamnetin prevents acute inflammation through blocking of NF-κB activation. Food and Chemical Toxicology 59: 362–372.CrossRefPubMed
20.
Zurück zum Zitat Saud, S.M., M.R. Young, Y.L. Jones-Hall, L. Ileva, M.O. Evbuomwan, J. Wise, N.H. Colburn, Y.S. Kim, and G. Bobe. 2013. Chemopreventive activity of plant flavonoid isorhamnetin in colorectal cancer is mediated by oncogenic Src and β-catenin. Cancer Research 73: 5473–5484.CrossRefPubMed Saud, S.M., M.R. Young, Y.L. Jones-Hall, L. Ileva, M.O. Evbuomwan, J. Wise, N.H. Colburn, Y.S. Kim, and G. Bobe. 2013. Chemopreventive activity of plant flavonoid isorhamnetin in colorectal cancer is mediated by oncogenic Src and β-catenin. Cancer Research 73: 5473–5484.CrossRefPubMed
21.
Zurück zum Zitat Dou, W., J. Zhang, H. Li, S. Kortagere, K. Sun, L. Ding, G. Ren, Z. Wang, and S. Mani. 2014. Plant flavonol isorhamnetin attenuates chemically induced inflammatory bowel disease via a PXR-dependent pathway. Journal of Nutritional Biochemistry 25: 923–933.CrossRefPubMedPubMedCentral Dou, W., J. Zhang, H. Li, S. Kortagere, K. Sun, L. Ding, G. Ren, Z. Wang, and S. Mani. 2014. Plant flavonol isorhamnetin attenuates chemically induced inflammatory bowel disease via a PXR-dependent pathway. Journal of Nutritional Biochemistry 25: 923–933.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Wu, Y., M. Singer, F. Thouron, M. Alaoui-El-Azher, and L. Touqui. 2002. Effect of surfactant on pulmonary expression of type IIA PLA(2) in an animal model of acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 282: L743–L750.CrossRefPubMed Wu, Y., M. Singer, F. Thouron, M. Alaoui-El-Azher, and L. Touqui. 2002. Effect of surfactant on pulmonary expression of type IIA PLA(2) in an animal model of acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 282: L743–L750.CrossRefPubMed
23.
Zurück zum Zitat Luo, Y., B. Zhang, D.Q. Xu, Y. Liu, M.Q. Dong, P.T. Zhao, and Z.C. Li. 2011. Protective effect of on lipopolysaccharide-induced acute lung injury in mice. Pulmonary Pharmacology & Therapeutics 24: 240–246.CrossRef Luo, Y., B. Zhang, D.Q. Xu, Y. Liu, M.Q. Dong, P.T. Zhao, and Z.C. Li. 2011. Protective effect of on lipopolysaccharide-induced acute lung injury in mice. Pulmonary Pharmacology & Therapeutics 24: 240–246.CrossRef
24.
Zurück zum Zitat Yin, H., X.Y. Li, B.H. Yuan, B.B. Zhang, S.L. Hu, H.B. Gu, X.B. Jin, and J.Y. Zhu. 2011. Adenovirus-mediated overexpression of soluble ST2 provides a protective effect on lipopolysaccharide-induced acute lung injury in mice. Clinical and Experimental Immunology 164: 248–255.CrossRefPubMedPubMedCentral Yin, H., X.Y. Li, B.H. Yuan, B.B. Zhang, S.L. Hu, H.B. Gu, X.B. Jin, and J.Y. Zhu. 2011. Adenovirus-mediated overexpression of soluble ST2 provides a protective effect on lipopolysaccharide-induced acute lung injury in mice. Clinical and Experimental Immunology 164: 248–255.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Mecklenburgh, K., J. Murray, T. Brazil, C. Ward, A.G. Rossi, and E.R. Chilvers. 1999. Role of neutrophil apoptosis in the resolution of pulmonary in ammation. Monaldi Archives for Chest Disease 54: 345–349.PubMed Mecklenburgh, K., J. Murray, T. Brazil, C. Ward, A.G. Rossi, and E.R. Chilvers. 1999. Role of neutrophil apoptosis in the resolution of pulmonary in ammation. Monaldi Archives for Chest Disease 54: 345–349.PubMed
26.
Zurück zum Zitat Klebanoff, S.J. 2005. Myeloperoxidase: friend and foe. Journal of Leukocyte Biology 77: 598–625.CrossRefPubMed Klebanoff, S.J. 2005. Myeloperoxidase: friend and foe. Journal of Leukocyte Biology 77: 598–625.CrossRefPubMed
27.
Zurück zum Zitat Strieter, R.M., and S.L. Kunkel. 1994. Acute lung injury: the role of cytokines in the elicitation of neutrophils. Journal of Investigative Medicine 42: 640–651.PubMed Strieter, R.M., and S.L. Kunkel. 1994. Acute lung injury: the role of cytokines in the elicitation of neutrophils. Journal of Investigative Medicine 42: 640–651.PubMed
28.
Zurück zum Zitat Kobayashi, A., S. Hashimoto, K. Kooguchi, Y. Kitamura, H. Onodera, Y. Urata, and T. Ashihara. 1998. Expression of inducible nitric oxide synthase and in ammatory cytokines in alveolar macrophages of ARDS following sepsis. Chest 113: 1632–1639.CrossRefPubMed Kobayashi, A., S. Hashimoto, K. Kooguchi, Y. Kitamura, H. Onodera, Y. Urata, and T. Ashihara. 1998. Expression of inducible nitric oxide synthase and in ammatory cytokines in alveolar macrophages of ARDS following sepsis. Chest 113: 1632–1639.CrossRefPubMed
29.
Zurück zum Zitat Shinbori, T., H. Walczak, and P.H. Krammer. 2004. Activated T killer cells induce apoptosis in lung epithelial cells and the release of pro-in ammatory cytokine TNF-alpha. European Journal of Immunology 34: 1762–1770.CrossRefPubMed Shinbori, T., H. Walczak, and P.H. Krammer. 2004. Activated T killer cells induce apoptosis in lung epithelial cells and the release of pro-in ammatory cytokine TNF-alpha. European Journal of Immunology 34: 1762–1770.CrossRefPubMed
30.
Zurück zum Zitat Giebelen, I.A., D.J. van Westerloo, G.J. LaRosa, A.F. de Vos, and T. van der Poll. 2007. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock 28: 700–703.PubMed Giebelen, I.A., D.J. van Westerloo, G.J. LaRosa, A.F. de Vos, and T. van der Poll. 2007. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock 28: 700–703.PubMed
31.
32.
Zurück zum Zitat Kang, J.L., H.W. Lee, H.S. Lee, I.S. Pack, Y. Chong, V. Castranova, and Y. Koh. 2001. Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide. American Journal of Respiratory and Critical Care Medicine 164: 2206–2212.CrossRefPubMed Kang, J.L., H.W. Lee, H.S. Lee, I.S. Pack, Y. Chong, V. Castranova, and Y. Koh. 2001. Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide. American Journal of Respiratory and Critical Care Medicine 164: 2206–2212.CrossRefPubMed
33.
Zurück zum Zitat Liu, S., G. Feng, G.L. Wang, and G.J. Liu. 2008. p38MAPK inhibition attenu-ates LPS-induced acute lung injury involvement of NF-kappaB pathway. European Journal of Pharmacology 584: 159–165.CrossRefPubMed Liu, S., G. Feng, G.L. Wang, and G.J. Liu. 2008. p38MAPK inhibition attenu-ates LPS-induced acute lung injury involvement of NF-kappaB pathway. European Journal of Pharmacology 584: 159–165.CrossRefPubMed
34.
Zurück zum Zitat Xia, Y.F., B.Q. Ye, Y.D. Li, J.G. Wang, X.J. He, X. Lin, X. Yao, D. Ma, A. Slungaard, R.P. Hebbel, N.S. Key, and J.G. Geng. 2004. Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. Journal of Immunology 173: 4207–4217.CrossRef Xia, Y.F., B.Q. Ye, Y.D. Li, J.G. Wang, X.J. He, X. Lin, X. Yao, D. Ma, A. Slungaard, R.P. Hebbel, N.S. Key, and J.G. Geng. 2004. Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. Journal of Immunology 173: 4207–4217.CrossRef
35.
Zurück zum Zitat Li, Q., and I.M. Verma. 2002. NF-kappa B regulation in the immune system. Nature Reviews Immunology 2: 725–734.CrossRefPubMed Li, Q., and I.M. Verma. 2002. NF-kappa B regulation in the immune system. Nature Reviews Immunology 2: 725–734.CrossRefPubMed
36.
Zurück zum Zitat Manca, D., A.C. Ricard, B. Trottier, and G. Chevalier. 1991. Studies on lipid peroxidation in rat tissues following administration of low and moderate doses of cadmium chloride. Toxicology 67: 303–323.CrossRefPubMed Manca, D., A.C. Ricard, B. Trottier, and G. Chevalier. 1991. Studies on lipid peroxidation in rat tissues following administration of low and moderate doses of cadmium chloride. Toxicology 67: 303–323.CrossRefPubMed
37.
Zurück zum Zitat Zhang, G., and S. Ghosh. 2001. Toll-like receptor-mediated NF-kB activation: a phylogenetically conserved paradigm in innate immunity. Journal of Clinical Investigation 107: 13–19.CrossRefPubMedPubMedCentral Zhang, G., and S. Ghosh. 2001. Toll-like receptor-mediated NF-kB activation: a phylogenetically conserved paradigm in innate immunity. Journal of Clinical Investigation 107: 13–19.CrossRefPubMedPubMedCentral
Metadaten
Titel
Isorhamnetin ameliorates LPS-induced inflammatory response through downregulation of NF-κB signaling
verfasst von
Yang Li
Gefu Chi
Bingyu Shen
Ye Tian
Haihua Feng
Publikationsdatum
02.05.2016
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 4/2016
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-016-0361-z

Weitere Artikel der Ausgabe 4/2016

Inflammation 4/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.